Testing GZR33 injection for type 2 diabetes control
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes diagnosed at least 6 months ago
- You've been on stable oral diabetes medications for at least 3 months
- You are between 18 and 75 years old (approximately)
- Your BMI is between 18.5 and 35.0 kg/m²
- You do not have type 1 diabetes or other specific types of diabetes
- You are willing to keep a consistent meal and exercise routine during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This trial tests how a single injection of a new drug called GZR4 is absorbed when given at different injection sites (like the belly or thigh) in healthy men. It helps researchers understand how the drug works in the body before testing it in people with diabetes.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.